NatureCellLtd Past Earnings Performance
Past criteria checks 0/6
NatureCellLtd has been growing earnings at an average annual rate of 75.3%, while the Biotechs industry saw earnings growing at 1.6% annually. Revenues have been growing at an average rate of 10.2% per year.
Key information
75.3%
Earnings growth rate
77.6%
EPS growth rate
| Biotechs Industry Growth | 11.7% |
| Revenue growth rate | 10.2% |
| Return on equity | -8.1% |
| Net Margin | -18.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How NatureCellLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 28,600 | -5,177 | 16,378 | 1,551 |
| 30 Jun 24 | 26,642 | -5,667 | 16,171 | 1,551 |
| 31 Mar 24 | 22,681 | -8,382 | 15,229 | 2,071 |
| 31 Dec 23 | 19,351 | -11,438 | 14,999 | 2,221 |
| 30 Sep 23 | 21,954 | -2,205 | 10,983 | 1,920 |
| 30 Jun 23 | 23,326 | -4,831 | 12,228 | 2,192 |
| 31 Mar 23 | 22,374 | -8,188 | 14,105 | 1,395 |
| 31 Dec 22 | 21,252 | -8,316 | 13,435 | 1,577 |
| 31 Dec 21 | 20,354 | -30,014 | 15,003 | 1,473 |
Quality Earnings: A007390 is currently unprofitable.
Growing Profit Margin: A007390 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A007390's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare A007390's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A007390 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-1.3%).
Return on Equity
High ROE: A007390 has a negative Return on Equity (-8.07%), as it is currently unprofitable.